FEI Tribunal issues Final Decisions

The FEI Tribunal has issued its Final Decisions in four cases involving Prohibited Substances.

The first case involves the horse Chabello (FEI ID 104OU26/MEX), ridden by Bruno Cavalheiro Rebello (FEI ID 10018978/BRA), which tested positive for the Banned Substance Ractopamine at the CSI2* in San Miguel de Allende (MEX), 3-6 October 2019. The FEI Tribunal approved the agreement reached on 30 January 2020 between the FEI and the athlete. As the FEI Tribunal accepted that the athlete bore no fault or negligence due to feed contamination, he will not serve any period of ineligibility other than the provisional suspension from 2 December 2019 to 3 February 2020. The results of the athlete and horse at the event were disqualified. Each of the parties will pay their own legal costs.

The second case involves the horse Veni Vidi Vici (FEI ID: 102MJ29/JOR), ridden by Huda Kayali (FEI ID: 10081862/JOR), which tested positive for the Banned Substance Stanozolol and its metabolite 16-beta-hydroxystanozolol at the CSIY-B, in Amman (JOR), 18-19 October 2018. The FEI Tribunal approved the agreement reached on 23 January 2020 between the FEI and the athlete. As the FEI Tribunal found that the athlete bore no significant fault or negligence, the athlete’s period of ineligibility was reduced to 17 months, starting on the date of notification (13 November 2018) until 12 April 2020. The results achieved by the athlete and horse at the event were disqualified. The athlete was ordered to pay a fine of CHF 5,000 and legal costs of CHF 2,500.

The third case involves the horse HSM Cornelio (FEI ID: 104GP38/COL), ridden by Pablo Carreño Mora (FEI ID 10072192/COL), which tested positive for the Banned Substance Ractopamine at the CEI1* 80 in Ubate (COL), 19–20 August 2017. The FEI Tribunal approved the agreement reached on 31 January 2020 between the FEI and the athlete. As the FEI Tribunal accepted that the athlete bore no fault or negligence due to feed contamination, he will not serve any period of ineligibility except the 13 days’ provisional suspension from 7 to 30 November 2017.The results of the athlete and horse at the event were disqualified. Each of the parties will pay their own legal costs.

The fourth case involves the horse Saura De Fondcombe (FEI ID: 103CM83 /SUI), ridden by Nadja Peter Steiner (FEI ID: 10006562/SUI), which tested positive for the Banned Substance O-Desmethyltramadol at the CSI3*-W in Tetouan (MAR), 5-8 October 2017.

Following an application by the athlete, on 22 December 2017 the FEI Tribunal lifted the two-month provisional suspension of the horse, which had been imposed on 9 November 2017. Following a second application from the athlete, on 8 August 2018 the FEI Tribunal lifted her provisional suspension, imposed on 9 November 2017.

According to the FEI Tribunal Decision, the athlete will be suspended for a period of two years, while the period of the provisional suspension (9 November 2017 to 8 August 2018) shall be credited against the period of ineligibility imposed, meaning the athlete will be ineligible until 19 May 2021. The athlete was ordered to pay a fine of CHF 7,500, pay the cost of the B-sample analysis and contribute CHF 2,000 to the costs.

The Final Decisions on these cases can be found here.

The parties can appeal to the Court of Arbitration for Sport (CAS) within 21 days of receipt of the decisions.

Separately, the FEI has announced a new adverse analytical finding (AAF) involving an equine prohibited substance. The case involves a *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

In the following Endurance case, the trainer has been provisionally suspended until the FEI Tribunal renders its decision. The horse has been provisionally suspended for two months from the date of notification. As this case involves a minor, the name of the athlete and horse are withheld.

Horse: N/A
Person Responsible: N/A
Trainer: Ghanim Mohd Al Marri (FEI ID 10048641/UAE)
Event: CEI2* 120 - Bou Thib (UAE), 12-13.12.2019
Prohibited Substance(s): Testosterone
Date of notification: 19 February 2020 (horse); 20 February (trainer)

In the two following cases the athletes refused to submit the horses to sample collection and have been provisionally suspended until the FEI Tribunal renders its decision.

Horse: Sarem (FEI ID 105MZ22/KSA)
Person Responsible: Mohammed Almalky (FEI ID: 10134839/KSA)
Trainer: Meshary Almalky (FEI ID:10158793/KSA)
Event: CEI2* 120 - Al Ula (KSA), 01.02.2020
Violation: refusal to submit to sample collection
Date of notification: 19 February 2020

Horse: Kenya De Safray (FEI ID 105AK13/FRA)
Person Responsible: Marine Jobin (FEI ID: 10035870/FRA)
Event: CSI1* - Le Touquet (FRA), 02-05.05.2019
Violation: refusal to submit to sample collection
Date of notification: 21 February 2020

Details on these cases can be found here.

Notes to Editors:

FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.

In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.

Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.